Graph
Peer review journals only publish new, important, innovative articles. This is how researchers communicate and in turn how new cures are found.|
We are dedicated to improving the cure rates of women with gynecologic and breast cancer through innovative clinical research.
Birthdays, showers & commemorative services are a great time to ask friends and family to make a donation. (Click here to donate)
Dr. John V. Brown presents Founders Award We strive to find the newest and most effective cancer treatments, having developed collaborative relationships with prominent pharmaceutical and biotech companies, including: Merck, Amgen, Eli Lilly, Genentech-Roche, Pfizer, Endocyte, Centocor Ortho Biotech, Nektar Therapeutics, Abbott Laboratories and Sunesis Pharmaceuticals, Inc. The Women’s Cancer Research Foundation emphasizes offering Phase II and Phase III clinical trials to women afflicted with breast and gynecologic (endometrial, uterine and ovarian) cancer. Additionally, the Women’s Cancer Research Foundation emphasizes publishing the results of our clinical trial research. We are nearing 100 publications in our eleventh year, 16 publications in 2010 alone. The Women’s Cancer Research Foundation is a 501(c)(3) tax-exempt non-profit organization. |
Judy Burton 2013
|
